secwatch.observer — SEC 8-K summary
======================================

Issuer:     CHAMPIONS ONCOLOGY, INC. (CSBR)
CIK:        0000771856
Form:       8-K
Filed at:   2022-10-20T23:59:59+00:00
Accession:  0001628280-22-026738
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Champions Oncology stockholders elect all seven director nominees at 2022 Annual Meeting
--------------------------------------------------------------------------------

- Seven directors elected: Ronnie Morris, Joel Ackerman, David Sidransky, Daniel Mendelson, Robert Brainin, Scott Tobin, Philip Breitfeld.
- Ratification of EisnerAmper LLP as independent auditor for FY2023 passed with 9,231,979 votes for.
- Non-binding advisory vote on named executive officer compensation approved with 9,025,636 votes for.
- All proposals passed with strong majority; no broker non-votes reported.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/771856/000162828022026738/0001628280-22-026738-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/771856/000162828022026738/csbr-20221020.htm
  HTML page:      https://secwatch.observer/filing/0001628280-22-026738

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer